KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.380
+0.170 (4.04%)
Mar 23, 2026, 11:02 AM EDT - Market open
KORU Medical Systems Employees
KORU Medical Systems had 73 employees as of December 31, 2025. The number of employees decreased by 7 or -8.75% compared to the previous year.
Employees
73
Change (1Y)
-7
Growth (1Y)
-8.75%
Revenue / Employee
$563,389
Profits / Employee
-$36,136
Market Cap
203.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 73 | -7 | -8.75% | 73 | 0 |
| Dec 31, 2024 | 80 | -2 | -2.44% | 80 | 0 |
| Dec 31, 2023 | 82 | -4 | -4.65% | 82 | 0 |
| Dec 31, 2022 | 86 | 9 | 11.69% | 85 | 1 |
| Dec 31, 2021 | 77 | -24 | -23.76% | 77 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 1,850 |
| AngioDynamics | 675 |
| OraSure Technologies | 500 |
| Harvard Bioscience | 355 |
| Nyxoah | 184 |
| Pro-Dex | 181 |
| Anteris Technologies Global | 174 |
| Utah Medical Products | 167 |
KRMD News
- 10 days ago - KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility - Business Wire
- 10 days ago - KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - KORU Medical Systems Announces CEO Transition - Business Wire
- 10 days ago - KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance - Business Wire
- 24 days ago - KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - Business Wire
- 7 weeks ago - KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System - Business Wire
- 2 months ago - KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow - Business Wire
- 2 months ago - KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire